Government subsidies and policies for mask production under COVID-19: Is it wise to control less?

X Xu, TM Choi, SH Chung… - IEEE Transactions on …, 2022 - ieeexplore.ieee.org
Under the COVID-19 pandemic, governments worldwide have subsidized manufacturers or
consumers on the production or purchase of masks. However, the impacts of these …

Product line extensions and distribution channels in pharmaceutical supply chain

R Tao, Y Lan, R Zhao, R Gao - European Journal of Operational Research, 2024 - Elsevier
In response to aggressive generic competition after the original drug's patent expires,
various original firms extend their product lines by introducing an authorized generic drug …

Incentivizing Drug Rediscovery: Exclusivity Extension and Priority Review for Repurposed Therapeutics

F Bravo, E Adida - Available at SSRN, 2025 - papers.ssrn.com
Drug repurposing consists in identifying new indications for existing drugs. Compared to de
novo drug development, drug repurposing incurs less risk and costs and requires less time …

Supply chain resilience and social welfare enhancement under COVID-19 pandemic

X Xu - 2023 - theses.lib.polyu.edu.hk
The outbreak of COVID-19 has posed serious threats and challenges to supply chain
management (SCM). Even though the pandemic has been announced as all over since 5 …

[หนังสือ][B] Public Policy and Risk Management in the US Pharmaceutical Supply Chain

M Hughes - 2023 - search.proquest.com
Supply chain risk management and public policy are both complex and ever-changing fields
that continually affect each other across many industries including the United States (US) …